Tag: biotechnology
GeneDx Stock Analysis: Buy or Sell? Valuation, Cash Flow & Margins
GeneDx Holdings Corp. (WGS) is rated Sell as the market prices in a clean earnings recovery that cash flow and margin trends do not yet support. Revenue growth is improving, but positive free cash flow remains elusive and reimbursement pressure could delay a rerating.